A Single-arm, Prospective, Phase II Clinical Study of the Combination of Entinostat and Oral Paclitaxel in the Treatment of HR+HER2- Advanced Breast Cancer
Clinical trial NCT07441486 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07441486
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2026-04-10
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.